Search

You searched for "cardiovascular"

294 results found
Current Eye Research journal cover image.

Short-term effects of intravitreal bevacizumab on the cornea

1 December 2014 | | EYE - Cornea, EYE - General | anterior chamber depth, bevacizumab, central corneal thickness, intraocular pressure, iridocorneal angle, simulated keratometry
Bevacizumab has been extensively used to treat macula oedema and neovascularisation of the retina and it has also been useful in the management of corneal neovascular diseases. This prospective study aimed to provide more information on the effect bevacizumab may...

Do bilateral same day intravitreal injections increase the risk of endophthalmitis?

1 February 2019 | | EYE - Vitreo-Retinal
This large retrospective cohort study reviewed all patients who had bilateral intravitreal anti-vascular endothelial growth factor (VEGF) injections between April 2012 and August 2017. There were 101,932 procedures performed in 5890 patients. The two most common indications for injections were...
British Journal of Ophthalmology cover

Features of AMD treatment non-responders

1 October 2019 | | EYE - Vitreo-Retinal
This is a retrospective consecutive case series of 365 eyes with age-related macular degeneration (AMD) who had three monthly intravitreal aflibercept treatments for at least 12 months. Responders were defined as complete resolution of exudation, intraretinal oedema, subretinal fluid, pigment...
JCRS journal cover image.

Delayed angle closure in pseudophakia and repeated intravitreal therapy

4 February 2021 | | EYE - Cataract, EYE - Refractive
The authors report two cases of acute angle closure many years after uneventful cataract surgery and posterior chamber intraocular lens (IOL) implantation. Both patients had neovascular age-related macular degeneration (AMD) and received regular intravitreal injections (24 and 25 injections in...
Progress in Retinal and Eye Research journal cover image.

Why is there subretinal fluid at the macula?

3 June 2021 | | EYE - Vitreo-Retinal | Central serous chorioretinopathy (CSC), Differential diagnosis, Retinal disease, Serous fluid accumulation, Serous maculopathy
This is a review article looking at the differential diagnosis of subretinal fluid in the macula that could be diagnosed as central serous chorioretinopathy (CSCR). The authors have categorised them into 12 groups: neovascular diseases, vitelliform lesions, inflammatory diseases, ocular...
Current Eye Research journal cover image.

Brolucizumab in age-related macular degeneration, HAWK Study

3 October 2023 | | EYE - Vitreo-Retinal | Neovascular age-related macular degeneration, aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, commercial formulation
The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...
Ophthalmology journal front cover image.

Anti-VEGF injections and macular atrophy progression in patients with nAMD in remission

3 February 2026 | | EYE - Vitreo-Retinal
This is a retrospective study of 59 eyes with neovascuar age-related macular degeneration (nAMD) with at least 6-month remission, to determine the effect of continuing anti-VEGF injections on the progression of macular atrophy (MA) during remission of nAMD. Group 1...

Poppers retinopathy: What is it and how do we treat it?

2 June 2025 | | EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...

Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review

1 February 2017 | | EYE - Neuro-ophthalmology
Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...

Addressing diabetes-related complications in Tanzania and Eswatini: A comprehensive approach to eye and foot screening

2 October 2025 | | EYE - Imaging
Diabetes is rising globally, particularly in low- to middle-income countries (LMICs), where healthcare systems are under resourced [1,2]. Among its complications, diabetic retinopathy (DR) and diabetic foot disease are preventable yet frequently overlooked [3-6]. These problems often develop together due...

Does vitrectomy increase the risk of glaucoma? A retrospective review from a UK hospital

5 April 2022 | | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - General
The authors investigate what proportion of patients undergoing pars plana vitrectomy subsequently developed ocular hypertension or a diagnosis of glaucoma. A systematic review carried out in 2017 including seven studies found that there is evidence that pars plana vitrectomy (PPV)...

Neovascular AMD: fresh recommendations underline standards of best practice

1 December 2013 |
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...